TSX:ACB - Toronto Stock Exchange - CA05156X8504 - Common Stock - Currency: CAD
TSX:ACB (7/23/2025, 7:00:00 PM)
6.63
-0.24 (-3.49%)
The current stock price of ACB.CA is 6.63 CAD. In the past month the price increased by 21.21%. In the past year, price decreased by -17.43%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
BHC.CA | BAUSCH HEALTH COS INC | 1.75 | 3.34B | ||
CRON.CA | CRONOS GROUP INC | 15.72 | 1.09B | ||
TLRY.CA | TILRAY BRANDS INC | N/A | 1.03B | ||
DHT-UN.CA | DRI HEALTHCARE TRUST | 6.94 | 826.17M | ||
GUD.CA | KNIGHT THERAPEUTICS INC | 55.64 | 609.74M | ||
WEED.CA | CANOPY GROWTH CORP | N/A | 334.09M | ||
CPH.CA | CIPHER PHARMACEUTICALS INC | 25.96 | 325.89M | ||
OGI.CA | ORGANIGRAM GLOBAL INC | 35 | 281.15M | ||
NGEN.CA | NERVGEN PHARMA CORP | N/A | 276.75M | ||
HITI.CA | HIGH TIDE INC | N/A | 264.71M | ||
XLY.CA | AUXLY CANNABIS GROUP INC | 15 | 200.29M | ||
TSND.CA | TERRASCEND CORP | N/A | 185.00M |
Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,073 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. The company also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.
AURORA CANNABIS INC
2207 90B Street Sw
Leduc ALBERTA T9E 0V6 CA
CEO: Miguel Martin
Employees: 1073
Phone: 16043625207
The current stock price of ACB.CA is 6.63 CAD. The price decreased by -3.49% in the last trading session.
The exchange symbol of AURORA CANNABIS INC is ACB and it is listed on the Toronto Stock Exchange exchange.
ACB.CA stock is listed on the Toronto Stock Exchange exchange.
10 analysts have analysed ACB.CA and the average price target is 9.42 CAD. This implies a price increase of 42.15% is expected in the next year compared to the current price of 6.63. Check the AURORA CANNABIS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
AURORA CANNABIS INC (ACB.CA) has a market capitalization of 363.72M CAD. This makes ACB.CA a Small Cap stock.
AURORA CANNABIS INC (ACB.CA) currently has 1073 employees.
AURORA CANNABIS INC (ACB.CA) has a support level at 6.16 and a resistance level at 6.85. Check the full technical report for a detailed analysis of ACB.CA support and resistance levels.
The Revenue of AURORA CANNABIS INC (ACB.CA) is expected to grow by 11.5% in the next year. Check the estimates tab for more information on the ACB.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ACB.CA does not pay a dividend.
AURORA CANNABIS INC (ACB.CA) will report earnings on 2025-08-07, before the market open.
The PE ratio for AURORA CANNABIS INC (ACB.CA) is 132.6. This is based on the reported non-GAAP earnings per share of 0.05 and the current share price of 6.63 CAD. Check the full fundamental report for a full analysis of the valuation metrics for ACB.CA.
ChartMill assigns a technical rating of 3 / 10 to ACB.CA. When comparing the yearly performance of all stocks, ACB.CA is a bad performer in the overall market: 85.6% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to ACB.CA. While ACB.CA seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months ACB.CA reported a non-GAAP Earnings per Share(EPS) of 0.05. The EPS increased by 106.11% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 0.66% | ||
ROA | 0.27% | ||
ROE | 0.4% | ||
Debt/Equity | 0.14 |
ChartMill assigns a Buy % Consensus number of 74% to ACB.CA. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of 578.72% and a revenue growth 11.5% for ACB.CA